Stoke Therapeutics Inc

+2.26 (+6.77%)
Earnings Announcements

Stoke Therapeutics Says Had $287.5 Mln In Cash As Of Dec. 31, 2020

Published: 03/09/2021 12:56 GMT
Stoke Therapeutics Inc (STOK) - Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates.
Stoke Therapeutics - As of Dec 31, 2020, Had $287.5 Million in Cash, Cash Equivalents & Restricted Cash, Anticipated to Fund Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.50

More details on our Analysts Page.